Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin (Q44214693)

30 November 2017

Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin (English)

1 reference

experimental autoimmune encephalomyelitis

30 November 2017

0 references

author name string

Romesh Stanislaus

1

1 reference

30 November 2017

Anne G Gilg

2

1 reference

30 November 2017

Avtar K Singh

3

1 reference

30 November 2017

Inderjit Singh

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

333

1 reference

30 November 2017

3

1 reference

30 November 2017

167-170

1 reference

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Cytokines in inflammatory brain lesions: helpful and harmful

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900943-6

7 January 2021

10.1016/S0304-3940(02)00943-6

Identifiers

DOI

1 reference

30 November 2017

1 reference